Profile
| Metric | Value |
|---|---|
| Full Name | Lyell Immunopharma, Inc. |
| Ticker | NASDAQ: LYEL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lyell.com |
| Employees | 300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $28.98 | |
| Price, 1D Change | -5.85% | |
| $429M | ||
| - | ||
| - | ||
| 1.24 | ||
| $61K | ||
| Revenue, 1Y Change | -53.08% | |
| -$26.23 | ||
| EPS, 1Y Change | -2,706.46% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$26.23 | ||
| EPS Estimate | -$10.61 | |
| EPS Est. Change | +59.57% | |
| $61.00K | ||
| Revenue Estimate | $22.50K | |
| Revenue Est. Change | -63.11% | |
| Current Price | $28.98 | |
| Price Target | - | $32.00 |
| Price Tgt. Change | - | +10.42% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.96 | -$0.93 | +2.63% | |
| -$0.58 | -$26.23 | -4,423.24% | |
| -$10.61 | N/A | +59.57% | |
| -$9.05 | N/A | +65.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.07M | $130.00K | -93.72% | |
| $53.00K | $61.00K | +15.09% | |
| $22.50K | N/A | -63.11% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $28.98 | |
| $14.29 | ||
| SMA 200 vs Price | -50.70% | |
| $24.04 | ||
| SMA 50 vs Price | -17.04% | |
| 1.24 | ||
| $3.13 | ||
| 47.95 | ||
| 111.73% | ||
| 111.51% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $61.00K | ||
| -$26.23 | ||
| -$19.57M | ||
| -32.08% | ||
| -$220.27M | ||
| -361.10% | ||
| -$342.99M | ||
| -562.29% | ||
| -$200.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 7.06 | ||
| 7.06 | ||
| - | ||
| 2 | ||
| -2.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 10.47K | ||
| 1.30 | ||
| -0.86 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $382.82M | ||
| $105.60M | ||
| $490.86M | ||
| $379.59M | ||
| $108.04M | ||
| $53.79M | ||
| $58.97M | ||
| $7.97M | ||
| $5.37M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $220.34M | ||
| $220.34M | ||
| $19.63M | ||
| $52.04M | ||
| $19.63M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$162.39M | ||
| $122.42M | ||
| $1.33M | ||
| $464.00K | ||
| -$162.86M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| LUCID CAPITAL MARKETS | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with LYEL
Data Sources & References
- LYEL Official Website www.lyell.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1806952/000162828025051619/0001628280-25-051619-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806952/000162828025011978/0001628280-25-011978-index.htm
- LYEL Profile on Yahoo Finance finance.yahoo.com/quote/LYEL
- LYEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lyel
FAQ
What is the ticker symbol for Lyell Immunopharma, Inc.?
The ticker symbol for Lyell Immunopharma, Inc. is NASDAQ:LYEL
Does Lyell Immunopharma, Inc. pay dividends?
No, Lyell Immunopharma, Inc. does not pay dividends
What sector is Lyell Immunopharma, Inc. in?
Lyell Immunopharma, Inc. is in the Healthcare sector
What industry is Lyell Immunopharma, Inc. in?
Lyell Immunopharma, Inc. is in the Biotechnology industry
What country is Lyell Immunopharma, Inc. based in?
Lyell Immunopharma, Inc. is headquartered in United States
When did Lyell Immunopharma, Inc. go public?
Lyell Immunopharma, Inc. initial public offering (IPO) was on June 17, 2021
Is Lyell Immunopharma, Inc. in the S&P 500?
No, Lyell Immunopharma, Inc. is not included in the S&P 500 index
Is Lyell Immunopharma, Inc. in the NASDAQ 100?
No, Lyell Immunopharma, Inc. is not included in the NASDAQ 100 index
Is Lyell Immunopharma, Inc. in the Dow Jones?
No, Lyell Immunopharma, Inc. is not included in the Dow Jones index
When was Lyell Immunopharma, Inc. last earnings report?
Lyell Immunopharma, Inc.'s most recent earnings report was on November 12, 2025
When does Lyell Immunopharma, Inc. report earnings?
The next expected earnings date for Lyell Immunopharma, Inc. is March 11, 2026